|
KMID : 0614620000360020192
|
|
Korean Journal of Gastroenterology
2000 Volume.36 No. 2 p.192 ~ p.202
|
|
|
Expression and Alternative Splicing Variant of Gastrin Cholecystokinin Type B Receptor in Gastric Cancer
|
|
Hwang You-Jin
Yoo Jong-Hyun
Choi Duck-Joo
Park Jong-Jae
Kim Sun-Suk
Oh Jae-Hwan
Lee Woon-Gi
Kang Dong-Hoon
|
|
|
Abstract
|
|
|
Background/Aims : Gastrin exert a variety of biologic actions in the brain and gastrointestinal tract through cholecystokinin receptors. Gastrin/cholecystokinin type B receptor (CCK-BR) mRNA has been shown in some colorectal cell lines and gastrointestinal tumors. While human CCK-BR has been characterized, the relative role of their isoforms in gastrointestinal cancer remains unclear. We investigated expression of CCK-BR and its isoform in normal and malignant tissues obtained from patients with gastric cancer according to anatomic location of the primary lesion, histologic type, and extent of disease.
Methods : RT-PCR was used to evaluate mRNA expression of CCK-BR and its isoforms in cancer and normal samples obtained from 44 patients with gastric adenocarcinoma. The expression of long-type isoform transcripts of CCK-BR was evaluated by Southern blot analysis.
Results : CCK-BR was expressed in 33/44 (75%) of malignant tissues and 36/39 (92.3%) of normal tissues obtained from the patients. By AJCC classification, CCK-BR transcript was detected in 33.3% of patients in IA stage, 50% of IB, 54.5% of II, 81.8% of IIIA, and 100% of both IIIB and IV. Long-type isoform transcript of CCK-BR was detected in 14/30 (46.7%) of malignant tissues and 23/31 (74.2%) of normal tissues of patients with gastric cancer.
Conclusions : In conclusion, the expression of CCK-BR indicates tumor grade and presence of metastatic disease, and loss of long isoform transcript of CCK-BR may be relate with the processing of gastric cancer.
|
|
|
KEYWORD
|
|
|
CCK Type B receptor, Splicing variant, Gastric cancer
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
   
|